IFF
44
-3
MRK
66
-2
FOX
35
2
CHD
61
-3
HBAN
54
3
PYPL
47
-2
CCL
33
-6
TDC
70
3
SWKS
38
-15
NWL
37
-4
ETN
78
-2
CCI
33
3
MSFT
55
2
NOV
48
3
OKE
56
-3
SYK
55
-5
GE
67
-3
FTI
81
-3
CA
12
-8
SHW
46
3
IFF
44
-3
MRK
66
-2
FOX
35
2
CHD
61
-3
HBAN
54
3
PYPL
47
-2
CCL
33
-6
TDC
70
3
SWKS
38
-15
NWL
37
-4
ETN
78
-2
CCI
33
3
MSFT
55
2
NOV
48
3
OKE
56
-3
SYK
55
-5
GE
67
-3
FTI
81
-3
CA
12
-8
SHW
46
3
Financhill
Back

Pacira BioSciences Quote, Financials, Valuation and Earnings

Earn Your Weekly "Paycheck" with Chuck's Secret Income Strategy!

Act now for your path to extra income!
Sell
45

PCRX
Pacira BioSciences

Last Price:
27.33
Seasonality Move:
2.24%

7 Day Trial

ALL ACCESS PASS

$ 7

My #1 Coin is...

All the details are on the next page.

Pacira BioSciences Price Quote

$27.33
+0.38 (+1.41%)
(Updated: May 2, 2024 at 6:55 PM ET)

Pacira BioSciences Key Stats

Sell
45
Pacira BioSciences (PCRX) is a Sell
Day range:
$26.27 - $27.12
52-week range:
$25.33 - $45.45
Dividend yield:
0%
P/E ratio:
30.28
P/S ratio:
2.19
P/B ratio:
1.44%
Volume:
449.6K
Avg. volume:
440.2K
1-year change:
-42.17%
Market cap:
$1.3B
Revenue:
$675M
EPS:
$0.83

How Much Does Pacira BioSciences Make?

Is Pacira BioSciences Growing As A Company?

  • What Is Pacira BioSciences's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.05%
  • What Is Pacira BioSciences's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Pacira BioSciences Stock Price Performance

What Is Pacira BioSciences 52-Week High & Low?

Pacira BioSciences Price To Free Cash Flow

Is It Risky To Buy Pacira BioSciences?

  • How Much Debt Does Pacira BioSciences Have?
    Total long term debt quarterly is $522.4M
  • How Much Cash Does Pacira BioSciences Have?
    Cash and short term investments quarterly total is $278.6M
  • What Is Pacira BioSciences’s Book Value Per Share?
    Book value per share is 18.72

Is Pacira BioSciences Cash Flow Positive?

  • What Is PCRX Cash Flow From Operations?
    Cash flow from operations (TTM) is $154.6M
  • What Is Pacira BioSciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$183M
  • What Is Pacira BioSciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $77.5M

Pacira BioSciences Return On Invested Capital

  • Is Management Doing A Good Job?
    PCRX return on invested capital is 3.04%
  • What Is Pacira BioSciences Return On Assets?
    ROA measures how assets are converting to revenues and is 2.67%
  • What Is PCRX Return On Equity?
    ROE is a measure of profitability and is 5.18%

Pacira BioSciences Earnings Date & Stock Price

Pacira BioSciences Competitors

Pacira BioSciences Dividend Yield

Data Unavailable

Pacira BioSciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 4.6%
Revenue: 5.4% 0.21%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 45.73
Upside from Last Price: 69.67%

Major Shareholders

  • How many PCRX shares are owned by institutional investors?
    76.3M PCRX shares are owned by institutional investors
  • How many PCRX shares are owned by insiders?
    1M PCRX shares are owned by insiders